BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
18 results:

  • 1. Identification of distinct genomic features reveals frequent somatic AHNAK and PTEN mutations predominantly in primary malignant melanoma presenting in the ureter.
    Huang Y; Wei L; Huang Y; Wen S; Liu T; Duan X; Wang Y; Zhang H; Fan B; Hu B
    Jpn J Clin Oncol; 2022 Aug; 52(8):930-943. PubMed ID: 35578896
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The immune regulation of bcl3 in glioblastoma with mutated IDH1.
    Fan S; Wu N; Chang S; Chen L; Sun X
    Aging (Albany NY); 2022 Apr; 14(9):3856-3873. PubMed ID: 35488886
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Value of tumor growth rate in evaluating the early therapeutic efficacy of neuroendocrine neoplasm].
    Zhou YT; Xia YF; Li Y; Zhu YJ; Chi Y; Jiang L
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1000-1006. PubMed ID: 35399019
    [No Abstract]    [Full Text] [Related]  

  • 4. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
    Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
    Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development of a model to predict vestibular schwannoma growth: An opportunity to introduce new wait and scan strategies.
    Hentschel MA; Hannink G; Steens SCA; Mulder JJS; Rovers MM; Kunst HPM
    Clin Otolaryngol; 2021 Jan; 46(1):273-283. PubMed ID: 33090707
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of tumor-Infiltrating Lymphocytes on Overall Survival in Merkel cell Carcinoma.
    Butala AA; Jain V; Reddy VK; Sebro RA; Song Y; Karakousis G; Mitchell TC; Lukens JN; Shabason JE
    Oncologist; 2021 Jan; 26(1):63-69. PubMed ID: 32886418
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Sex matters: men with melanoma have a worse prognosis than women.
    El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ; Louwman MWJ; Kukutsch NA
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2062-2067. PubMed ID: 31246315
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A novel four‑snoRNA signature for predicting the survival of patients with uveal melanoma.
    Yi Q; Zou WJ
    Mol Med Rep; 2019 Feb; 19(2):1294-1301. PubMed ID: 30569172
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
    Zanello M; Roux A; Ursu R; Peeters S; Bauchet L; Noel G; Guyotat J; Le Reste PJ; Faillot T; Litre F; Desse N; Emery E; Petit A; Peltier J; Voirin J; Caire F; Barat JL; Vignes JR; Menei P; Langlois O; Dezamis E; Carpentier A; Dam Hieu P; Metellus P; Pallud J;
    J Neurooncol; 2017 Nov; 135(2):285-297. PubMed ID: 28726173
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and predictive value of YKL-40 in stage IIB-III melanoma.
    Krogh M; Christensen I; Bouwhuis M; Johansen JS; Nørgaard P; Schmidt H; Hansson J; Suciu S; Eggermont AM; Bastholt L;
    Melanoma Res; 2016 Aug; 26(4):367-76. PubMed ID: 27076041
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD34 Over-Expression is Associated With Gliomas' Higher WHO Grade.
    Kong X; Guan J; Ma W; Li Y; Xing B; Yang Y; Wang Y; Gao J; Wei J; Yao Y; Xu Z; Dou W; Lian W; Su C; Ren Z; Wang R
    Medicine (Baltimore); 2016 Feb; 95(7):e2830. PubMed ID: 26886640
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High CD133 Expression Is Associated with Worse prognosis in Patients with Glioblastoma.
    Zhang W; Chen H; Lv S; Yang H
    Mol Neurobiol; 2016 May; 53(4):2354-60. PubMed ID: 25983032
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma.
    Li R; Gao K; Luo H; Wang X; Shi Y; Dong Q; Luan W; You Y
    J Exp Clin Cancer Res; 2014 Jan; 33(1):9. PubMed ID: 24438238
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells.
    Garate M; Wani AA; Li G
    Free Radic Biol Med; 2010 Jun; 48(12):1601-9. PubMed ID: 20226854
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic factors of liver metastases from uveal melanoma.
    Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatment of liver metastases from uveal melanoma.
    Rivoire M; Kodjikian L; Baldo S; Kaemmerlen P; Négrier S; Grange JD
    Ann Surg Oncol; 2005 Jun; 12(6):422-8. PubMed ID: 15886904
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998.
    Kunschner LJ; Kuttesch J; Hess K; Yung WK
    Neuro Oncol; 2001 Jul; 3(3):167-73. PubMed ID: 11465397
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Recurrence of thin melanoma: how effective is follow-up?
    Moloney DM; Gordon DJ; Briggs JC; Rigby HS
    Br J Plast Surg; 1996 Sep; 49(6):409-13. PubMed ID: 8881790
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.